.

Deeper Knowledge, Faster

  • Plan your formulary budget
  • Drug patents in 130+ countries
  • Set up watchlists for daily email updates

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

US Department of Justice
Covington
Chinese Patent Office
Argus Health
Colorcon
Johnson and Johnson
Mallinckrodt
Cantor Fitzgerald
Harvard Business School
Novartis

Generated: July 21, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 018866

« Back to Dashboard
NDA 018866 describes BETAMETHASONE VALERATE, which is a drug marketed by Taro Pharm, Perrigo Uk Finco, Riconpharma Llc, Actavis Mid Atlantic, Sti Pharma Llc, Perrigo New York, Pharmaderm, Fougera, Taro, Teva Pharms, and Pharmafair, and is included in eighteen NDAs. It is available from thirteen suppliers. Additional details are available on the BETAMETHASONE VALERATE profile page.

The generic ingredient in BETAMETHASONE VALERATE is betamethasone valerate. There are sixty-six drug master file entries for this compound. Seventeen suppliers are listed for this compound. Additional details are available on the betamethasone valerate profile page.

Summary for NDA: 018866

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:1
Therapeutic Class:Hormonal Agents, Stimulant/Replacement/Modifying (Adrenal)
Formulation / Manufacturing:see details

Pharmacology for NDA: 018866

Suppliers and Packaging for NDA: 018866

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
BETAMETHASONE VALERATE
betamethasone valerate
LOTION;TOPICAL 018866 NDA E. Fougera & Co. a division of Fougera Pharmaceuticals Inc. 0168-0041 0168-0041-60 60 mL in 1 BOTTLE (0168-0041-60)
BETAMETHASONE VALERATE
betamethasone valerate
LOTION;TOPICAL 018866 ANDA Physicians Total Care, Inc. 54868-5002 54868-5002-0 60 mL in 1 BOTTLE (54868-5002-0)

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:LOTION;TOPICALStrengthEQ 0.1% BASE
Approval Date:Aug 31, 1983TE:ABRLD:Yes


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

UBS
Queensland Health
Mallinckrodt
McKinsey
McKesson
Cerilliant
Farmers Insurance
QuintilesIMS
Harvard Business School
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot